Febrile Seizure

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read here. Clinical judgment based on individual patient circumstances is paramount.

---

Overview

• Definition: A febrile seizure is a seizure occurring in a child typically between 6 months and 5 years of age, associated with fever (temperature generally ≥38.0°C or 100.4°F), not caused by an intracranial infection or acute metabolic derangement, and occurring in the absence of a history of afebrile seizures. It is a diagnosis of exclusion.
• Epidemiology:
  • Most common type of seizure in childhood.
  • Affects 2% to 5% of children, with higher prevalence in certain populations (e.g., Japan, India).
  • Peak incidence is between 12 and 18 months of age.
  • Slight male predominance.
  • Approximately one-third of children who experience a febrile seizure will have recurrences.
• Classification: Febrile seizures are classified into two main types based on clinical characteristics:
  • Simple Febrile Seizure (most common, ~80-85% of cases):
    • Generalized (tonic-clonic, tonic, clonic, or atonic).
    • Duration typically less than 15 minutes.
    • Does not recur within 24 hours (or within the same febrile illness).
  • Complex Febrile Seizure (~15-20% of cases):
    • Focal onset or focal features during the seizure.
    • Duration ≥15 minutes.
    • Multiple seizures occurring within 24 hours or during the same febrile illness.
    • Any combination of the above.

Pathophysiology

• Mechanism: The exact mechanism is not fully understood but involves a complex interplay of fever-induced changes in neuronal excitability, the immature developing brain, and genetic predisposition.
  • Fever: Rapid rise or presence of high fever likely triggers the seizure. Cytokines (e.g., IL-1β, TNF-α) released during infection may contribute to neuronal hyperexcitability.
  • Immature Brain: The developing brain of infants and young children is inherently more susceptible to seizures due to differences in neuronal networks, neurotransmitter systems (e.g., immature GABAergic inhibition, excitatory glutamatergic system), and ion channel function compared to older children and adults.
  • Genetic Predisposition: There is a strong genetic component, with a family history of febrile seizures significantly increasing risk. Specific gene mutations affecting ion channels (e.g., SCN1A, SCN2A, GABRG2) have been identified in a subset of individuals, particularly those with complex febrile seizures or specific febrile seizure syndromes (e.g., Genetic Epilepsy with Febrile Seizures Plus [GEFS+]).
• Risk Factors:
  • Age: 6 months to 5 years (peak 12-18 months).
  • Family History: First-degree relative with febrile seizures.
  • Temperature: Higher fever (often >39°C/102.2°F) or rapid rise in temperature.
  • Infections: Viral infections are most common (e.g., Human Herpesvirus 6 [HHV-6] causing roseola, influenza, adenovirus, enterovirus). Bacterial infections can also be associated.
  • Vaccinations: Rarely, certain vaccinations can be followed by fever and febrile seizures (e.g., MMR, DTaP-IPV-Hib).
  • Perinatal Factors: Prematurity, neonatal intensive care unit (NICU) admission (less consistently linked).
• Protective Factors: No specific factors are known to reliably protect against the initial occurrence of febrile seizures, beyond general health and avoidance of high fevers (which is not a primary prevention strategy for febrile seizures themselves). Prevention focuses more on reducing recurrence risk or complications.

Clinical Presentation

Signs and Symptoms

• Cardinal Features:
  • Occurs during a febrile illness (often the first day of fever).
  • Generalized tonic-clonic seizure activity: Stiffening of the body (tonic phase), followed by rhythmic jerking of all limbs (clonic phase).
  • Eyes may roll back or deviate.
  • Loss of consciousness.
  • Drooling or foaming at the mouth.
  • Cyanosis or pallor can occur during the seizure.
  • Brief duration (most simple febrile seizures last 1-2 minutes).
  • Post-ictal drowsiness or confusion (typical).
• Early Signs: Typically, there are no specific early warning signs for the seizure itself beyond the presence of fever. The seizure is often the first sign parents notice of a significant illness.
• Advanced Signs: Not applicable as febrile seizures are acute events. The "advanced" state would refer to prolonged seizures (febrile status epilepticus).
• Atypical Presentations: These fall under the definition of complex febrile seizures:
  • Focal Features: Seizure activity localized to one side of the body or a single limb, or eye deviation that persists to one side.
  • Prolonged Duration: Seizure lasting ≥15 minutes.
  • Recurrence: More than one seizure within 24 hours or during the same febrile illness.

Physical Examination

• Inspection:
  • During Seizure: Observation of seizure type, duration, and associated features (e.g., cyanosis, eye deviation).
  • Post-Ictal: Level of consciousness (drowsiness, lethargy), signs of injury from the seizure.
  • General: Assess for signs of the underlying febrile illness (e.g., rash, respiratory distress, signs of dehydration).
• Palpation:
  • Temperature: Crucial to confirm fever.
  • Fontanelle: In infants, assess for bulging fontanelle, which could suggest increased intracranial pressure or meningitis.
  • Neck Stiffness: Check for nuchal rigidity (meningismus), a sign of meningitis, though often difficult to assess in young children, especially when post-ictal.
• Special Tests:
  • Neurological Examination: After the seizure, once the child is alert and cooperative, a thorough neurological exam should be performed to assess for any focal deficits or signs of intracranial pathology. A transient Todd's paralysis (post-ictal focal weakness) may be seen after a focal seizure.

Diagnostic Approach

History Taking

• Key Questions:
  • Seizure Description: Exact time of onset and duration, type of movements (generalized, focal, rhythmic), eye deviation, color changes, level of consciousness, post-ictal state. Did the child recover to baseline?
  • Fever History: Onset, highest temperature measured, how temperature was measured, associated symptoms (e.g., cough, rhinorrhea, vomiting, diarrhea, rash), presence of a known source of infection.
  • Past Medical History: Previous febrile or afebrile seizures, developmental history (milestones), chronic medical conditions, recent illnesses or hospitalizations.
  • Family History: History of febrile seizures, epilepsy, or other neurological conditions in parents or siblings.
  • Medications: Any current medications.
  • Immunization Status: Up-to-date on routine vaccinations, especially meningococcal and Hib.
• Red Flags: Warning signs that necessitate further investigation to rule out more serious conditions (e.g., meningitis, encephalitis, underlying epilepsy):
  • Age <6 months or >5 years at first seizure.
  • Complex febrile seizure features (focal, prolonged ≥15 min, multiple within 24h).
  • Persistent focal neurological deficit after the seizure.
  • Signs suggestive of meningitis/encephalitis: significant lethargy/irritability, nuchal rigidity, bulging fontanelle, petechial rash, protracted vomiting.
  • No return to baseline mental status within a few hours.
  • Suspicion of non-accidental trauma (e.g., in the absence of clear fever source).

Laboratory Tests

• First-Line: For a simple febrile seizure in a child who appears well and returns to baseline, laboratory testing is generally not routinely recommended by the American Academy of Pediatrics (AAP) guidelines (reaffirmed 2021). The focus is on identifying the source of the fever.
  • Consider directed testing (e.g., urinalysis/urine culture for suspected UTI, rapid viral tests for influenza/RSV) based on the child's age, clinical presentation, and local epidemiology.
  • Electrolytes, glucose, calcium, magnesium are not routinely needed unless there is clinical suspicion of metabolic derangement.
• Confirmatory:
  • Lumbar Puncture (LP): Indicated if there is clinical suspicion of meningitis or encephalitis. This includes:
    • Any signs or symptoms of meningeal irritation (e.g., nuchal rigidity, bulging fontanelle, significant lethargy/irritability).
    • Uncertain immunization status for Haemophilus influenzae type b (Hib) or Streptococcus pneumoniae.
    • After a complex febrile seizure, if clinical suspicion remains high.
    • Infants <12 months of age, as signs of meningitis can be subtle. LP is strongly considered, especially in those 6-12 months.
    • Children between 12 and 18 months, LP is considered, but clinical judgment may allow for close observation if no meningeal signs.
    • Children >18 months, LP is generally not necessary in the absence of meningeal signs or symptoms.
• Monitoring: Not applicable for diagnosis, but monitoring of inflammatory markers (e.g., CRP, procalcitonin) may be done if a bacterial infection is suspected and to guide antibiotic therapy.

Imaging

• Recommended: Neuroimaging (CT or MRI) is not routinely recommended for simple febrile seizures.
• Advanced: Neuroimaging may be considered in specific circumstances:
  • Evidence of increased intracranial pressure.
  • Presence of persistent focal neurological deficits after the seizure.
  • Macrocephaly or other abnormal head growth.
  • Signs of a significant head trauma.
  • First complex febrile seizure, especially if followed by a prolonged post-ictal state or abnormal neurological examination.
  • EEG (electroencephalogram) is not routinely recommended after a first simple febrile seizure due to its limited utility in predicting future afebrile seizures or epilepsy. It may be considered in specific cases of complex febrile seizures, persistent neurological abnormalities, or strong clinical suspicion of an underlying seizure disorder.

Management

Acute Management

• Immediate: Focus on ensuring the child's safety and managing the ongoing seizure if present.
  • Airway, Breathing, Circulation (ABCs): Maintain a clear airway by placing the child in a recovery position (on their side) to prevent aspiration. Do not put anything in the child's mouth. Ensure adequate breathing; supplemental oxygen may be needed if cyanotic or prolonged seizure.
  • Time the Seizure: Crucial for determining management. Use a clock or stopwatch.
  • Do Not Restrain: Protect the child from injury by clearing surrounding objects.
• Stabilization:
  • For seizures lasting >5 minutes: Consider abortive therapy to prevent febrile status epilepticus.
    • Rectal Diazepam: 0.5 mg/kg (max 20 mg), may be repeated once after 4-12 minutes if seizure persists. Onset 2-10 minutes.
    • Buccal/Intranasal Midazolam: 0.2-0.3 mg/kg (max 10 mg). Onset 2-5 minutes.
    • Intravenous (IV) Lorazepam: 0.1 mg/kg (max 4 mg) slowly over 2-5 minutes. Can be repeated once. Onset 1-3 minutes. This is preferred in hospital settings due to faster action and less respiratory depression than IV diazepam.
• Emergency: For febrile status epilepticus (seizure lasting ≥30 minutes, or recurrent seizures without return to baseline in between for 30 min):
  • Follow general status epilepticus protocols.
  • First-line: Benzodiazepines (as above).
  • Second-line: If benzodiazepines fail, consider IV fosphenytoin (phenytoin equivalent 15-20 mg/kg), IV levetiracetam (20-60 mg/kg), or IV valproate (20-40 mg/kg).
  • Refractory status epilepticus: May require continuous infusions of medications like midazolam, propofol, or pentobarbital in an intensive care setting.
  • Identify and Treat Cause: While managing the seizure, simultaneously evaluate and treat the underlying source of fever or any other contributing factors.

Chronic Management

• Pharmacological:
  • Antipyretics: Antipyretics (e.g., acetaminophen 10-15 mg/kg every 4-6 hours, ibuprofen 5-10 mg/kg every 6-8 hours) are recommended for fever reduction to improve comfort, but they have not been shown to prevent recurrence of febrile seizures.
  • Prophylactic Antiepileptic Drugs (AEDs): Not recommended for the prevention of simple febrile seizures or recurrent febrile seizures due to potential side effects (sedation, cognitive impairment, behavioral issues, idiosyncratic reactions) outweighing the minimal benefit of preventing a generally benign event. Continuous AEDs (e.g., phenobarbital, valproate) are only considered in very rare, highly specific circumstances (e.g., multiple prolonged complex febrile seizures in a child with pre-existing neurological deficit) after careful discussion of risks and benefits with parents.
  • Intermittent Prophylaxis: Intermittent oral diazepam at the onset of fever has been studied but is not routinely recommended due to significant side effects (ataxia, lethargy, irritability) and only modest reduction in recurrence risk.
• Non-pharmacological:
  • Parental Education and Reassurance: This is the cornerstone of chronic management.
    • Educate parents about the benign nature of simple febrile seizures.
    • Provide instructions on what to do if another seizure occurs (safety, timing, when to seek emergency care).
    • Address parental anxiety, which is often high after a child's first seizure.
    • Explain that antipyretics are for comfort, not seizure prevention.
• Monitoring:
  • No specific medical monitoring is needed after a simple febrile seizure if the child has returned to baseline and the cause of fever is identified and managed.
  • Follow-up with the primary care physician is usually sufficient for ongoing health supervision and to address any parental concerns.
  • Referral to a pediatric neurologist may be considered for complex febrile seizures or if there are concerns about underlying neurological issues.

Treatment Algorithms

• First-Line:
  1. Immediate: Ensure safety during the seizure (ABC, recovery position, clear area). Time the seizure.
  2. Duration <5 minutes: Observe and provide supportive care. Assess for underlying cause of fever. Educate parents.
  3. Duration ≥5 minutes (or ongoing): Administer benzodiazepine (rectal diazepam, buccal/intranasal midazolam, or IV lorazepam).
• Second-Line (for status epilepticus after benzodiazepine failure):
  1. IV fosphenytoin (or phenytoin).
  2. IV levetiracetam.
  3. IV valproate.
• Refractory Cases (for status epilepticus unresponsive to first and second-line agents):
  1. Transfer to Intensive Care Unit (ICU).
  2. Continuous infusions of midazolam, propofol, or pentobarbital.
  3. Consider metabolic workup, neuroimaging, and EEG monitoring.

Complications

• Common:
  • Recurrence: Approximately 30-50% of children will have another febrile seizure, especially if they are younger at the first seizure (<18 months), have a low-grade fever at the time of seizure, have a family history of febrile seizures, or have a short duration of fever prior to the seizure.
  • Parental Anxiety: Significant psychological stress for parents watching their child seize.
• Serious:
  • Febrile Status Epilepticus (FSE): Seizure lasting ≥30 minutes. While usually benign, prolonged FSE can rarely be associated with hippocampal injury or subtle cognitive sequelae, particularly in children with pre-existing vulnerabilities. However, most children with FSE have a good long-term outcome.
  • Accidental Injury: Injuries sustained during the seizure (e.g., from falling, hitting objects).
  • Misdiagnosis: Failure to diagnose a serious underlying condition (e.g., meningitis, encephalitis, undiagnosed epilepsy).
• Long-term:
  • Epilepsy: The risk of developing subsequent afebrile epilepsy after a simple febrile seizure is only slightly increased compared to the general population (1% vs. 0.5-1%). This risk is primarily linked to pre-existing risk factors, not the simple febrile seizure itself. Risk factors for developing epilepsy after febrile seizures include:
    • Pre-existing neurological abnormality or developmental delay.
    • Complex febrile seizure features (especially focal or prolonged).
    • Family history of afebrile epilepsy.
    • Multiple febrile seizure recurrences (less strong as an independent risk factor).
  • Cognitive/Behavioral Outcomes: Simple febrile seizures do not cause brain damage or impair cognitive development, academic performance, or behavior. Even after febrile status epilepticus, most children have normal cognitive outcomes.

Prognosis

• Factors:
  • Simple Febrile Seizure: Excellent prognosis. No increased risk of mortality, brain damage, or intellectual disability.
  • Complex Febrile Seizure: Still generally good prognosis, but a slightly higher, though still low, risk of developing epilepsy compared to simple febrile seizures.
  • Risk Factors for Epilepsy: As noted above (pre-existing neurological deficit, complex features, family history of epilepsy).
• Survival: Excellent. Febrile seizures are not associated with increased mortality.
• Quality of Life: Unaffected by simple febrile seizures. While the initial event can be frightening for families, the long-term impact on the child's quality of life is negligible in the vast majority of cases.

Prevention

• Primary: Preventing the initial occurrence of a febrile seizure is not routinely feasible or recommended. Strategies like continuous antipyretic use for fever prevention are ineffective and carry potential side effects.
• Secondary: Aims to prevent recurrence.
  • Antipyretics: While important for comfort, routine or continuous antipyretic use has not been shown to prevent febrile seizure recurrence. Parents should still be advised to use them for fever to alleviate discomfort.
  • Intermittent Antiepileptics: Intermittent oral diazepam given at the onset of fever has been shown to reduce recurrence rates, but its use is not recommended by major guidelines (e.g., AAP) due to significant side effects (sedation, ataxia, irritability) that often outweigh the benefit of preventing a generally benign event.
  • Continuous Antiepileptics: Chronic daily antiepileptic drugs are not recommended due to significant side effects and the benign nature of most febrile seizures.
• Tertiary: Focuses on preventing complications, primarily managing prolonged seizures quickly to minimize potential rare adverse outcomes.
  • Educate parents on how to manage a seizure at home (safety, timing, when to call emergency services).
  • For children with a history of prolonged febrile seizures, parents may be prescribed a rescue benzodiazepine (e.g., rectal diazepam, buccal midazolam) to administer if a seizure lasts more than 5 minutes. This should be discussed with a neurologist.

Special Populations

• Pediatric: Febrile seizures are exclusive to the pediatric population (6 months to 5 years). Considerations include:
  • Infants <6 months: A seizure with fever in this age group is typically not a febrile seizure and warrants a full septic workup including LP, given the higher risk of serious bacterial infection and subtle signs of meningitis.
  • Children >5 years: A first seizure with fever in this age group is also unusual for a simple febrile seizure and may prompt further investigation for underlying epilepsy or other neurological conditions.
• Geriatric: Not applicable.
• Pregnancy: Not applicable.
• Comorbidities: Children with pre-existing neurological conditions (e.g., cerebral palsy, developmental delay) are not typically diagnosed with "febrile seizures" as defined. Their seizures, even with fever, are often considered provoked seizures in the context of their underlying neurological condition and warrant a different evaluation and management approach, often involving a neurology specialist.

Clinical Pearls

• Diagnostic:
  • Febrile seizure is a diagnosis of exclusion. Always rule out CNS infection (meningitis, encephalitis) and metabolic derangements.
  • The key distinction is simple vs. complex. This guides the extent of workup.
  • Do not routinely order labs or imaging for simple febrile seizures in well-appearing children who return to baseline. Focus on the source of fever.
  • Lumbar puncture is critical if meningitis is suspected, especially in infants <18 months or if signs of meningeal irritation are present.
• Treatment:
  • Safety first during the seizure. Protect the child from injury.
  • Timely administration of rescue benzodiazepines for prolonged seizures (>5 minutes) can prevent febrile status epilepticus.
  • Antipyretics are for comfort, not for preventing recurrence of febrile seizures. Communicate this clearly to parents.
  • Chronic antiepileptic medications are NOT recommended for prevention due to poor risk-benefit profile.
• Pitfalls:
  • Over-investigating simple febrile seizures: Leads to unnecessary procedures, costs, and parental distress.
  • Under-investigating "atypical" presentations: Missing a serious underlying condition by assuming all fever-associated seizures are benign febrile seizures.
  • Failing to educate and reassure parents: Leading to persistent anxiety and misunderstanding about the benign nature of the condition.
  • Prescribing chronic antiepileptics: Puts the child at risk of side effects without significant benefit for a generally benign condition.
  • Confusing chills/rigors with seizures: True rigors involve shivering/shaking but consciousness is preserved; differentiate from seizure activity.

Recent Updates

• Guidelines: The American Academy of Pediatrics (AAP) last reaffirmed its practice guideline for the neurodiagnostic evaluation of the child with a simple febrile seizure in 2021, upholding the recommendations from 2011. These guidelines continue to emphasize limited diagnostic workup for well-appearing children after a simple febrile seizure.
• Evidence:
  • Ongoing research continues to refine the understanding of genetic predispositions for febrile seizures and the spectrum of genetic epilepsies with febrile seizures plus (GEFS+).
  • Studies consistently confirm the generally benign long-term neurodevelopmental outcome of simple febrile seizures, even after prolonged events (febrile status epilepticus), in the absence of pre-existing neurological conditions.
  • Focus has shifted towards early abortive therapy for prolonged seizures and careful exclusion of alternative diagnoses.
• Controversies:
  • The optimal management strategy for recurrent complex febrile seizures remains an area of debate, although chronic prophylaxis is generally discouraged.
  • The exact role and utility of genetic testing for idiopathic febrile seizures beyond a research context are still evolving.

Key References

• Guidelines:
  • American Academy of Pediatrics (AAP) Clinical Practice Guideline: Neurodiagnostic Evaluation of the Child With a Simple Febrile Seizure (2011, reaffirmed 2021). Pediatrics.
  • National Institute for Health and Care Excellence (NICE) Guidelines: Epilepsies in children, young people and adults (2021).
• Studies:
  • Pruitt, D. W., & Prutsky, G. J. (2011). Neurodiagnostic Evaluation of the Child with a Simple Febrile Seizure. Pediatrics, 127(2), 389–394. (This is the AAP guideline paper).
  • Nelson, K. B., & Ellenberg, J. H. (1976). Predictors of epilepsy in children with febrile seizures. The New England Journal of Medicine, 295(19), 1029–1033. (Classic study on prognosis).
  • Shinnar, S., et al. (2008). Long-term outcomes of children with febrile status epilepticus. Epilepsia, 49(1), 59-67.
• Reviews:
  • Riviello, J. J., & Baren, J. M. (2023). Febrile Seizures. In UpToDate. (Accessed via institutional subscription).
  • Millichap, J. J. (2004). Febrile Seizures. Clinics in Perinatology, 31(1), 163–175.
  • Waruiru, C., & Wamae, N. (2020). Febrile Seizures: An Updated Review. Current Pediatric Reviews, 16(2), 79-85.